Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
出版年份 2020 全文链接
标题
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
作者
关键词
-
出版物
JOURNAL OF HEADACHE AND PAIN
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-09
DOI
10.1186/s10194-020-01143-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG
- (2020) Antonio Russo et al. NEUROLOGICAL SCIENCES
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
- (2020) Bianca Raffaelli et al. Frontiers in Neurology
- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- Episodic Migraine Comorbidities: Avoiding Pitfalls and Taking Therapeutic Opportunities
- (2019) Britany Klenofsky et al. Current Pain and Headache Reports
- Erenumab: from scientific evidence to clinical practice—the first Italian real-life data
- (2019) Piero Barbanti et al. NEUROLOGICAL SCIENCES
- Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
- (2019) Simona Lattanzi et al. DRUGS
- Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2019) Peter J Goadsby et al. CEPHALALGIA
- Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
- (2019) Kristian Agmund Haanes et al. CNS DRUGS
- Erenumab in chronic migraine
- (2019) Richard B. Lipton et al. NEUROLOGY
- New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
- (2019) Damiana Scuteri et al. Frontiers in Pharmacology
- Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
- (2019) Messoud Ashina et al. CEPHALALGIA
- Recent Advances in Pharmacotherapy for Episodic Migraine
- (2019) Calvin Chan et al. CNS DRUGS
- Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2019) Dawn C. Buse et al. HEADACHE
- Novel Medications for the Treatment of Migraine
- (2019) Claire E. J. Ceriani et al. HEADACHE
- Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
- (2019) Messoud Ashina et al. CEPHALALGIA
- Allodynia in Menstrually Related Migraine: Score Assessment by Allodynia Symptom Checklist (ASC‐12)
- (2019) Eliana Meire Melhado et al. HEADACHE
- The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
- (2019) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Migraine progression in subgroups of migraine based on comorbidities
- (2019) Richard B. Lipton et al. NEUROLOGY
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs
- (2018) Jonathan Jia Yuan Ong et al. DRUGS
- CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
- (2018) Kasra Maasumi et al. DRUGS
- Poor medical care for people with migraine in Europe – evidence from the Eurolight study
- (2018) Zaza Katsarava et al. JOURNAL OF HEADACHE AND PAIN
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms
- (2018) Angeliki Vgontzas et al. HEADACHE
- Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
- (2018) Lars Bendtsen et al. JOURNAL OF HEADACHE AND PAIN
- Cognitive dysfunction and migraine
- (2018) Doga Vuralli et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns
- (2017) Janet H. Ford et al. HEADACHE
- Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
- (2017) Cristina Tassorelli et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topiramate in Migraine Prevention: A 2016 Perspective
- (2016) Stephen D. Silberstein HEADACHE
- Shared Genetic Factors Underlie Migraine and Depression
- (2016) Yuanhao Yang et al. Twin Research and Human Genetics
- The impact of cognitive symptoms on migraine attack-related disability
- (2015) Raquel Gil-Gouveia et al. CEPHALALGIA
- Cutaneous allodynia as a predictor of migraine chronification
- (2013) Mark A. Louter et al. BRAIN
- Italian guidelines for primary headaches: 2012 revised version
- (2012) Paola Sarchielli et al. JOURNAL OF HEADACHE AND PAIN
- Depression and risk of transformation of episodic to chronic migraine
- (2012) Sait Ashina et al. JOURNAL OF HEADACHE AND PAIN
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: Development and validation
- (2011) Raquel Gil-Gouveia et al. CEPHALALGIA
- Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
- (2010) Min Yang et al. CEPHALALGIA
- Increased Prevalence of Sleep Disorders in Chronic Headache: A Case-Control Study
- (2010) Elisa Sancisi et al. HEADACHE
- Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
- (2010) D C Buse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Current practice and future directions in the prevention and acute management of migraine
- (2010) Peter J Goadsby et al. LANCET NEUROLOGY
- Minimal Important Differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1
- (2009) JC Cole et al. CEPHALALGIA
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
- (2008) S Silberstein et al. CEPHALALGIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started